Wyeth Manufacturing Improvements Extend To Drug R&D, Exec Says
Executive Summary
Wyeth is incorporating manufacturing quality assurance assessments into its drug R&D process as part of its efforts to ensure the company continually meets good manufacturing practice standards
You may also be interested in...
Wyeth Packaging Problems Lead To Warning Letter, Triphasil-28 Recall
Wyeth failed to adequately investigate cases of contamination involving a packaging extractable for two oral contraceptive drugs manufactured at the firm's Guayama, Puerto Rico facility, FDA states in a recent warning letter
Wyeth Packaging Problems Lead To Warning Letter, Triphasil-28 Recall
Wyeth failed to adequately investigate cases of contamination involving a packaging extractable for two oral contraceptive drugs manufactured at the firm's Guayama, Puerto Rico facility, FDA states in a recent warning letter
FDA “Quality By Design” Initially Focuses On Post-Approval Manufacturing
FDA will focus initially on the post-approval regulatory pathway as the most likely starting point for firms instituting "quality by design" manufacturing